Association between mifepristone dose, efficacy, and tolerability in patients with Cushing syndrome.
Yuen et al. • 2015 • Endocr Pract. 2015;21(10):1087-92.
© 2024 Corcept Therapeutics, Incorporated
Mifepristone and Cushing syndrome: A commentary.
Kennedy L. • 2015 • Endocr Pract. 2015;21(10):1175-7.